ライフサイエンスコーパス: nitric

1 isotopic composition of atmospheric nitrate (nitric acid (HNO(3)) + particulate nitrate (pNO(3)(-)))

2 ia merging a droplet of an ionic liquid with nitric acid (HNO(3)), and the coalescence of a solid par

3 is cold enough (below -15 degrees Celsius), nitric acid and ammonia can nucleate directly through an

4 Even though rapid growth from nitric acid and ammonia condensation may last for only a

5 We also expect nitric acid and ammonia nucleation and rapid growth to b

6 t CERN, that below about +5 degrees Celsius, nitric acid and ammonia vapours can condense onto freshl

7 ations, we analyze the interface affinity of nitric acid and provide an order of magnitude for its li

8 ain insight into the properties of molecular nitric acid at the surface of liquid water (the air-wate

9 ntly by a water-mediated process (leading to nitric acid formation), while the lifetime of a similar

10 which has huge environmental relevance since nitric acid is a component of acid rain and also contrib

11 cted from the continental boundary layer and nitric acid is abundant from electrical storms(4,5).

12 The slag was dissolved in nitric acid to generate an acid solution containing 23.5

13 ysed post hoc by baseline fractional exhaled nitric oxide (<35 and >=35 ppb) and blood eosinophil (<2

14 hing (+30%), nitrous oxide emissions (+30%), nitric oxide (+66%) emissions, and ammonia volatilizatio

15 of saturating solutions of CO (160 mum) and nitric oxide (100 mum).

16 lammation was assessed by fractional exhaled nitric oxide (FeNO) and exhaled breath condensate pH and

17 icosteroid adherence, and fractional exhaled nitric oxide (FeNO) in 17 studies for inhaled corticoste

18 Fraction of exhaled nitric oxide (FeNO) is a marker of eosinophilic airway i

19 t 2013 and February 2015, fractional exhaled nitric oxide (FeNO) was measured from 112 participants a

20 omuscular blockade, corticosteroids, inhaled nitric oxide (iNO), prone positioning, high-frequency os

21 b) and a 6 min inhalation of the vasodilator nitric oxide (iNO; 40 ppm in 21% O(2) ), to selectively

22 Protein S-nitrosylation, the nitric oxide (NO(*))-mediated posttranslational modifica

23 Nitric oxide (NO(-)) is a member of RNS produced from ar

24 emed to be endothelium dependent, as well as nitric oxide (NO) and guanylyl cyclase, but not prostagl

25 genomic approaches, we provide evidence that nitric oxide (NO) and oxylipin signalling pathways in di

26 A subset of these TFs is targeted each by nitric oxide (NO) and the phytochrome-interacting TF PIL

27 of evidence demonstrating that scavenging of nitric oxide (NO) and the reduction of nitrate/nitrite r

28 ction, due at least in part to reductions in nitric oxide (NO) bioavailability and associated vascula

29 onths of RT on sleep quality, redox balance, nitric oxide (NO) bioavailability, inflammation profile,

30 triction (FGR), due in part to reductions in nitric oxide (NO) bioavailability.

31 ickle cell disease (SCD), due in part to low nitric oxide (NO) bioavailability.

32 al-mediated routes for nitrite (NO(2)(-)) to nitric oxide (NO) conversion and phenol oxidation are of

33 discovered that KSHV hijacks the citrulline-nitric oxide (NO) cycle to promote growth proliferation

34 Constant therapeutic gas phase nitric oxide (NO) delivery is achieved from S-nitrosothi

35 cle, cytoglobin (Cygb) functions as a potent nitric oxide (NO) dioxygenase and regulates NO metabolis

36 Nitric oxide (NO) emerged as a key signal molecule in pl

37 ed with HbA1c and negatively correlated with nitric oxide (NO) in diabetic patients.

38 Real-time sensing of nitric oxide (NO) in physiological environments is criti

39 Chemical generation of nitric oxide (NO) in the absence of immune cells was suf

40 The short-lived hydrophobic gas nitric oxide (NO) is a broadly conserved signaling molec

41 Nitric oxide (NO) is a gaseous signaling molecule that p

42 Nitric oxide (NO) is a gasotransmitter with important ph

43 Nitric oxide (NO) is a gasotransmitter with important ro

44 Nitric oxide (NO) is a key signaling molecule that regul

45 Nitric oxide (NO) is a molecule of vast physiological si

46 Nitric oxide (NO) is a ubiquitous gaseous messenger, but

47 Nitric oxide (NO) is an important free radical synthesiz

48 Nitric oxide (NO) is an important signaling molecule tha

49 o investigate how the environmental stimulus nitric oxide (NO) is linked to biofilm dispersal, focusi

50 Nitric oxide (NO) is perfectly suited for the role of a

51 In addition, nitric oxide (NO) is produced from nitrate and nitrite,

52 a reduced growth and photosynthesis, altered nitric oxide (NO) level and leaf and root anatomy, inhib

53 n decompaction and increases oligodendrocyte nitric oxide (NO) levels.

54 reported concerning the effects of augmented nitric oxide (NO) on skeletal muscle force production an

55 dividual subunits, the KsNaxLS complex binds nitric oxide (NO) only at the distal heme side, forming

56 ransfer (PET) mechanism, we designed a smart nitric oxide (NO) probe, PYSNO, with high sensitivity an

57 Nitric oxide (NO) produced as a result of activation of

58 Nitric oxide (NO) produced by endothelial nitric oxide s

59 Here we demonstrate that nitric oxide (NO) produced by murine macrophages is resp

60 strated with pharmacological approaches that nitric oxide (NO) produced through the citrulline-NO pat

61 ntain mechanical strength, vasoactivity, and nitric oxide (NO) production for at least 4 weeks.

62 ically alters the transcriptome and triggers nitric oxide (NO) production in F. graminearum We identi

63 We observed nitric oxide (NO) production in human primary ECs stimul

64 ted with vascular complications and impaired nitric oxide (NO) production.

65 Nitric oxide (NO) regulates the deployment of a phalanx

66 controls pathogenesis via the regulation of nitric oxide (NO) resistance and inorganic nitrogen meta

67 y-activated tumor cells, iNOS expression and nitric oxide (NO) secretion were significantly increased

68 sorders are associated with perturbations to nitric oxide (NO) signaling and impaired glucose metabol

69 Endothelial dysfunction and reduced nitric oxide (NO) signaling are a key element of the pat

70 Nitric oxide (NO) signaling has been studied in the eye,

71 e neighbor to human vasodilatory endothelial nitric oxide (NO) signaling.

72 Endothelial cell nitric oxide (NO) synthase (eNOS), the enzyme responsibl

73 Interepithelial transfer of exosomal nitric oxide (NO) synthase and nitric oxide was measured

74 ement was abolished by pretreatment with the nitric oxide (NO) synthase inhibitor l-N (G)-nitro-l-arg

75 S2) which instantly fills the phagosome with nitric oxide (NO) to clear the pathogen.

76 pecific tyrosine residues and interaction of nitric oxide (NO) with the P450 heme are necessary for N

77 mor-promoting and immunosuppressive molecule nitric oxide (NO), whereas macrophages largely express a

78 on product (APOP), myeloperoxidase (MPO) and nitric oxide (NO), while depleting levels of endogenous

79 uman cytochrome P450 (P450) CYP2B6 undergoes nitric oxide (NO)-dependent proteasomal degradation in r

80 Among molecules modulating the nitric oxide (NO)-GMP-phosphodiesterase (PDE) pathway, t

81 he transduction of endothelium-dependent and nitric oxide (NO)-mediated vasodilator activity, given i

82 Nitric oxide (NO)-NO-sensitive (soluble) guanylyl cyclas

83 ant version of ZIP and by treatment with the nitric oxide (NO)-synthase inhibitor L-NAME.

84 tron acceptors such as nitrite (NO(2)(-)) or nitric oxide (NO).

85 de synthase (eNOS), an enzyme that generates nitric oxide (NO).

86 nia oxidizers by converting hydroxylamine to nitric oxide (NO).

87 ly sensitive to O(2) and highly sensitive to nitric oxide (NO).

88 >=150/300 cells/uL and/or fractional exhaled nitric oxide [FeNO] >=25 ppb), annualized severe exacerb

89 Locally generated nitric oxide activates the nitric oxide-sensitive cation

90 Here we show that the protective actions of nitric oxide against EMCV infection are selective for be

91 d an increase in the inhibition of hydroxyl, nitric oxide and alpha-amylase, as well as a decrease in

92 rved in the high baseline fractional exhaled nitric oxide and blood eosinophil subgroups (207 mL [95%

93 50] for the high baseline fractional exhaled nitric oxide and blood eosinophil subgroups, respectivel

94 le signaling processes such as production of nitric oxide and caveolae-mediated intracellular traffic

95 calmodulin nitrated at Tyr-138 produced more nitric oxide and did so more efficiently than WT calmodu

96 r that promotes vasorelaxation by increasing nitric oxide and downregulating endothelin-1 (ET-1) prod

97 l perfusion through vasodilation mediated by nitric oxide and hydrogen sulfide.

98 ich nanoparticles, oxidants that may destroy nitric oxide and impair endothelial function, but also l

99 re cytocidal activity against beta-cells via nitric oxide and induce autoimmune diabetes.

100 osation in response to exposure to both free nitric oxide and nitrosothiols (k (inact)/K(I) >= 5 m(-1

101 assessed innate immune indices (haptoglobin, nitric oxide and ovotransferrin concentrations, and haem

102 molecule generated from the reaction between nitric oxide and superoxide radicals, in impairing endot

103 ons in obese mice generated higher levels of nitric oxide and superoxide radicals, resulting in incre

104 data point towards haemoglobin scavenging of nitric oxide as a key regulatory factor of brachial flow

105 cterization revealed that in the presence of nitric oxide as a spin probe and oxygen surrogate, both

106 S), 2,2-diphenyl-1-picrylhydrazyl (DPPH) and nitric oxide assays.

107 gonorrhoeae blocks exfoliation by producing nitric oxide at the bacterial-host cell interface to pro

108 al at the ovule triggers the accumulation of nitric oxide at the filiform apparatus in a process that

109 itively, release of the vasodilator molecule nitric oxide attenuated endothelial TRPV4 channel activi

110 (1-methylnicotinamide, +33%; P=6.1x10(-67)), nitric oxide bioavailability (arginine/ornithine + citru

111 We hypothesized that low nitric oxide bioavailability due to the presence of cell

112 trogenase inactivation; and Glb1-1 modulates nitric oxide concentration during symbiosis, from the ea

113 One immune index, nitric oxide concentration showed a weak quadratic patte

114 to -0.77]) and had lower fractional exhaled nitric oxide concentrations (13.9 vs. 24.4 ppb; P < 0.00

115 sis following IGF-1 treatment, adenosine and nitric oxide contributed to hypoxia-mediated coronary va

116 rpose of this study was to determine whether nitric oxide contributes to the beta-cell response to vi

117 ), and at least 2 conditions associated with nitric oxide deficiency (diabetes, hypertension, obesity

118 tify glutamatergic signaling dysfunction and nitric oxide deficiency as yet-undescribed early manifes

119 n fraction (HFpEF) is often characterized by nitric oxide deficiency.

120 microbial nitrosative stress resistance and nitric oxide degradation.

121 lobins are cytoplasmic proteins required for nitric oxide detoxification and nitrosative stress resis

122 els and lung function and fractional exhaled nitric oxide did not differ by BMI category.

123 ADP-ribosylation reactions using a chemical nitric oxide donor S-nitrosoglutathione and enzymatic AD

124 um nitroprusside, an endothelium-independent nitric oxide donor.

125 itrite, which may subsequently be reduced to nitric oxide during conditions of hypoxia and in the pre

126 reduced production of the potent vasodilator nitric oxide during glutamatergic synaptic activity.

127 Specifically, nitric oxide emissions (NO) lead to increased smog, acid

128 f nitrate leaching, nitrous oxide emissions, nitric oxide emissions, and ammonia volatilization total

129 oped iron sulfide nanoclusters that catalyse nitric oxide generation from benign sodium nitrite in th

130 This nitric oxide generation platform may advance mechanistic

131 rotein 2 in vitro decreased NOS3 expression, nitric oxide generation, and angiogenesis.

132 unoblotting, proximity ligation as-says, and nitric oxide imaging, we report that phosphorylation of

133 s (RSNOs) serve as air-stable reservoirs for nitric oxide in biology.

134 ion of micromolar levels of the free radical nitric oxide in neighboring beta-cells.

135 y advance mechanistic studies of the role of nitric oxide in the nervous system and other organs.

136 The in situ generation of nitric oxide in the ventral tegmental area with the elec

137 We have recently shown that nitric oxide inhibits EMCV replication and EMCV-mediated

138 At these concentrations nitric oxide inhibits the Krebs enzyme aconitase and com

139 Preclinical models have demonstrated that nitric oxide is a key component of neurovascular couplin

140 Nitric oxide is a vital neurovascular signalling molecul

141 r coupling response by ~30%, indicating that nitric oxide is integral to neurovascular coupling in hu

142 odilatation and reduced resting steady-state nitric oxide levels in the blood Collectively, our data

143 ficantly correlated with fraction of exhaled nitric oxide levels.

144 es in line with temperate losses and raising nitric oxide losses above them.

145 erate and tropical croplands, although total nitric oxide losses were higher in the tropics.

146 monia, and pasture agroecosystems had higher nitric oxide losses.

147 ed on a combination of tests including nasal nitric oxide measurement, transmission electron microsco

148 ge and are accompanied by alterations in the nitric oxide metabolism.

149 bolism, hepatic steatosis, oxidative stress, nitric oxide modulation, and collagen metabolism.

150 Nitric oxide nitrosates both precursor and mature forms

151 mic haemodilution to assess the influence of nitric oxide on neurovascular coupling in humans.

152 ella strains induced apoptosis or stimulated nitric oxide or lactose dehydrogenase production in matu

153 activated the JAK/STAT1/IRF1 axis, inducing nitric oxide production and driving caspase-8/FADD-media

154 suring mechanosensing, which is essential to nitric oxide production and flow-induced vasodilation.

155 ortance of the simultaneous consideration of nitric oxide production and inactivation when investigat

156 osure to high glucose, with the reduction in nitric oxide production being the most notable.

157 nal hyperemia by suppressing NMDAR-dependent nitric oxide production during neural activity.

158 factor alpha (TNF-alpha) mRNA and increased nitric oxide production during T. parva lethal infection

159 vessel wall shear stress and, consequently, nitric oxide production may contribute to heightened sys

160 , regulates permeability, leukocyte traffic, nitric oxide production, and coagulation, and harbors di

161 factor-kappaB (NF-kappaB) subunit p65, lower nitric oxide production, and diminished CHOP expression

162 ctivator of transcription (STAT) pathway and nitric oxide production, as well as the promotion of ade

163 ency prevents NMDA receptors from triggering nitric oxide production, thereby attenuating the flow in

164 We show that nitric oxide protects beta-cells against virally mediate

165 The reduction of NO to N(2)O by flavodiiron nitric oxide reductases (FNORs) is related to the disrup

166 talloproteins related to beta-lactamases and nitric oxide reductases.

167 sis revealed that endogenous accumulation of nitric oxide resulted in up-regulation of genes involved

168 This may be mediated through the nitric oxide scavenging potency of CFH, increasing basal

169 rescued F508del-CFTR by arginine-dependent, nitric oxide signaling through inhibition of endogenous

170 us-pituitary-adrenal axis; and adenosine and nitric oxide signaling.

171 Nitric oxide signalling is integral to NVC in humans, pr

172 Changes in haematocrit influence nitric oxide signalling through alterations in shear str

173 ipheral endothelial function, likely through nitric oxide signalling.

174 in regulating cell growth and responding to nitric oxide stress in M. tuberculosis, but its underlyi

175 ime polymerase chain reaction of endothelial nitric oxide synthase (eNOS) and endothelin-1; (d) immun

176 ce K(+) (IK and SK) channels and endothelial nitric oxide synthase (eNOS) are present in the endothel

177 annels in some vascular beds and endothelial nitric oxide synthase (eNOS) in others.

178 Nitric oxide (NO) produced by endothelial nitric oxide synthase (eNOS) is a critical mediator of v

179 fragment of the shear-responsive endothelial nitric oxide synthase (eNOS) promoter, we tested effects

180 in (TM), a surface receptor, and endothelial nitric oxide synthase (eNOS), an enzyme that generates n

181 ated protein kinase (AMPK), Akt, endothelial nitric oxide synthase (eNOS), nuclear factor erythroid 2

182 skin wound angiogenesis through endothelial nitric oxide synthase (eNOS)-dependent Src, PI3K, and MA

183 PepNats representing hot loops of inducible nitric oxide synthase (iNOS) and human agouti-related pr

184 biomarkers include suppression of inducible nitric oxide synthase (iNOS) and induction of sterol reg

185 receptor (CB1R) and activation of inducible nitric oxide synthase (iNOS) are associated with nonalco

186 r of RNS produced from arginine by inducible Nitric Oxide Synthase (iNOS) enzyme.

187 s that are sufficient to stimulate inducible nitric oxide synthase (iNOS) expression and production o

188 showed that radiotherapy increased inducible nitric oxide synthase (iNOS) in the tumor tissues.

189 essions of interleukin (IL)-1beta, inducible nitric oxide synthase (iNOS), cyclooxygenase (COX)-2, ma

190 ta); and the inflammatory markers: Inducible Nitric Oxide Synthase (iNOS), Interleukin 1beta (IL-1bet

191 ro-apoptotic signaling mediated by inducible nitric oxide synthase (iNOS), transforming growth factor

192 nylate-binding proteins (GBPs) and inducible nitric oxide synthase (iNOS), which we found to inhibit

193 d corneal allograft survival in an inducible nitric oxide synthase (iNOS)-dependent manner.

194 erythroid-derived 2)-like 2 (Nrf2), neuronal Nitric Oxide Synthase (nNOS) expression and nitrergic re

195 olves a tau-induced dissociation of neuronal nitric oxide synthase (nNOS) from postsynaptic density 9

196 Neuronal nitric oxide synthase (nNOS) regulates muscle atrophy in

197 In the course of our studies on neuronal nitric oxide synthase (nNOS), a client of the Hsp90 and

198 Inhibition of neuronal nitric oxide synthase (nNOS), an enzyme implicated in ne

199 ide synthase 1 adaptor protein) and neuronal nitric oxide synthase (nNOS), nNOS enzymatic activity, a

200 es calcium signals in pyramidal and neuronal nitric oxide synthase (nNOS)-expressing neurons.

201 rvalbumin, calbindin, calretinin, and neural nitric oxide synthase (nNOS).

202 od flow (FBF) response to acetylcholine, and nitric oxide synthase (NOS) activity was defined as the

203 erized further by triple labeling with CGRP, nitric oxide synthase (NOS) and calretinin (CALR) antibo

204 While NO production by nitric oxide synthase (NOS) enzymes in the eye has been

205 -like 2 (Nrf2)/tetrahydrobiopterin (BH(4) )/ nitric oxide synthase (NOS) expression in primary human

206 phorase is used as a histochemical marker of nitric oxide synthase (NOS) in aldehyde-treated tissues.

207 We investigated the role of nitric oxide synthase (NOS) in mediating blood-brain bar

208 Nitric oxide synthase (NOS) inhibitors rescue this patho

209 ermined by lactate dehydrogenase release and nitric oxide synthase (NOS)-dependent cGMP production.

210 ed STAT1 and its downstream target inducible nitric oxide synthase (NOS2) as being upregulated in the

211 Rs) on the host cell, it activates inducible nitric oxide synthase (NOS2) which instantly fills the p

212 FNgamma-dependent genes, including inducible nitric oxide synthase (Nos2).

213 The endothelial nitric oxide synthase (NOS3) system is crucial for vascu

214 hyperoxia-induced BPD and PH via endothelial nitric oxide synthase (NOS3).

215 nergy balance (e.g. oxytocin (OXT), neuronal nitric oxide synthase 1 (NOS1), melanocortin 4-receptor

216 e, including the interaction between NOS1AP (nitric oxide synthase 1 adaptor protein) and neuronal ni

217 tide 3-phosphate kinase, Akt Ser/Thr kinase, nitric oxide synthase 1, nitric oxide, soluble guanylate

218 Inbred mice that lack the gene encoding nitric oxide synthase 2 (Nos2) are susceptible to the re

219 infection, and testing MAIT cell priming in nitric oxide synthase 2 (NOS2)-deficient mice all failed

220 CXCL9/CXCL10), and innate immunity-related (nitric oxide synthase 2/inducible nitric oxide synthase

221 Nitric oxide synthase 2/inducible nitric oxide synthase

222 receptor agonist analog elicited endothelial nitric oxide synthase activation to promote endothelial

223 r arginase level and activity, and decreased nitric oxide synthase activity.

224 y-related (nitric oxide synthase 2/inducible nitric oxide synthase and IL-17C) products (FDR < 0.05).

225 ed distinct anti-inflammatory (low inducible nitric oxide synthase and lower tumour necrosis factor-a

226 Increased activities of inducible nitric oxide synthase and NADPH oxidase 1 enzymes at myo

227 % of myenteric neurons stained with neuronal nitric oxide synthase antibody and approximately 33% of

228 l perfusion has been used to determine which nitric oxide synthase enzymes are active in discrete reg

229 Nitric oxide synthase 2/inducible nitric oxide synthase expression (determined by quantita

230 beta cells, which are mediated by inducible nitric oxide synthase expression and beta-cell productio

231 rotocols utilizing intravenous infusion of a nitric oxide synthase inhibitor and isovolumic haemodilu

232 (placebo) and the non-selective competitive nitric oxide synthase inhibitor N(G) -monomethyl-l-argin

233 Intravenous infusion of a nitric oxide synthase inhibitor reduced the neurovascula

234 and improve vascular function in endothelial nitric oxide synthase knockout (eNOS(-/-) ) mice.

235 mbers of nitrergic neurons, reduced neuronal nitric oxide synthase production, and reduced colonic ne

236 d investigated the role of 12,13-diHOME in a nitric oxide synthase type 1 deficient (NOS1(-/-)) mouse

237 osine kinase(Tek), isolectin B4, endothelial nitric oxide synthase(eNOS), von Willebrand factor(vWF),

238 helial growth factor), and eNOS (endothelial nitric oxide synthase) protein contents.

239 gressive blockade of adenosine receptors and nitric oxide synthase, and by modeling the determinants

240 hways, specifically MAPK/ERK1/2, endothelial nitric oxide synthase, and mammalian target of rapamycin

241 dase, uncoupling of endothelial and neuronal nitric oxide synthase, and vascular/brain infiltration w

242 neurons showed increased levels of inducible nitric oxide synthase, another indicator of cell damage.

243 A), an endogenous inhibitor and uncoupler of nitric oxide synthase, has gained attention as a risk fa

244 e molecules, including arginase 1, inducible nitric oxide synthase, signal transducer and activator o

245 ecrosis factor-alpha, interleukin-1beta, and nitric oxide synthase-2, highlighting the potential of V

246 ossibly by affecting the NF-kappaB-inducible nitric oxide synthase-endoplasmic reticulum stress pathw

247 alpha(+)]), and effector molecule (inducible nitric oxide synthase-positive [iNOS(+)]) responses were

248 actile inhibition via the enzyme endothelial nitric oxide synthase.

249 egregated population that expresses neuronal nitric oxide synthase.

250 ression revealed significant upregulation of nitric oxide synthetase (NOS1 and NOS3) and neuroprotect

251 lective manner, these findings indicate that nitric oxide targets the same metabolic pathways necessa

252 Fractional exhaled nitric oxide testing is recommended to assist in diagnos

253 yurea generates a protocell-mediated flux of nitric oxide that we exploit for in vitro and in vivo bl

254 paminergic neurons release both dopamine and nitric oxide to increase the flexibility of olfactory me

255 dependent NO reductases (cNOR), which reduce nitric oxide to nitrous oxide and water.

256 To investigate the contribution of nitric oxide to NVC in humans, we utilized a visual stim

257 t align in the direction of flow and produce nitric oxide under high shear stress.

258 r of exosomal nitric oxide (NO) synthase and nitric oxide was measured by using ELISAs and NO activit

259 lyzed by immunohistochemistry, and levels of nitric oxide were measured.

260 Understanding the function of nitric oxide, a lipophilic messenger in physiological pr

261 The therapeutic application of nitric oxide, an endogenous cellular signaling molecule,

262 roups and gasotransmitters (carbon monoxide, nitric oxide, and hydrogen sulfide).

263 n of nitrate to dinitrogen gas over nitrite, nitric oxide, and nitrous oxide.

264 NMDA receptors (NMDARs) play a role through nitric oxide, and the CBF increase produced by endotheli

265 CI, -32.9%, -10.2%), and fractional exhaled nitric oxide, CCL26 and SERPINB2 mRNA expression in bron

266 ctivity, characterised by the measurement of nitric oxide, endothelin-1, tissue plasminogen activator

267 e involved in redox signalling, for instance nitric oxide, hydrogen sulfide and oxidized lipids.

268 d to cause cell death by virtue of releasing nitric oxide, is highly unstable in air and is rapidly o

269 impact of various nitrogen oxides, including nitric oxide, nitrogen dioxide, and nitrous oxide, on ca

270 e and S-nitroso-N-acetyl-d,l-penicillamine), nitric oxide, oxidized GSH, and hydrogen peroxide to pos

271 Like nitric oxide, pharmacological inhibition of mitochondria

272 gulation, brain-derived neurotrophic factor, nitric oxide, renin-angiotensin).

273 Akt Ser/Thr kinase, nitric oxide synthase 1, nitric oxide, soluble guanylate cyclase, cyclic GMP (cGM

274 acula densa cells triggers the production of nitric oxide, which also contributes to glomerular hyper

275 truncated NOS2 protein that did not produce nitric oxide, which determined that the patient had auto

276 s novel insight into the mechanisms by which nitric oxide, which is produced in hepatocytes in respon

277 off axonal actin polymerization, mediated by nitric oxide-cyclic GMP signaling leading to inhibition

278 ting mitochondrial oxidative metabolism in a nitric oxide-dependent manner.

279 Furthermore, BFM improved nitric oxide-dependent vasorelaxation induced by acetylc

280 Collectively, these results suggest that nitric oxide-derived oxidants may causatively link nucle

281 Ageing impaired nitric oxide-mediated EDD (peak EDD 88 +/- 12% 6 months

282 anoclusters with multimaterial fibres allows nitric oxide-mediated neuronal interrogation in vivo.

283 gh selectivities toward other enzymes of the nitric oxide-modulating system.

284 The presence of the nitric oxide-scavenging protein, haemoglobin alpha, limi

285 Locally generated nitric oxide activates the nitric oxide-sensitive cation channel, transient recepto

286 (hemoglobin) and oxygen, carbon dioxide, and nitric oxide-the three-gas respiratory cycle-that insure

287 thase expression and beta-cell production of nitric oxide.

288 n of iNOS and production of the free radical nitric oxide.

289 n, paralysis, prone positioning, and inhaled nitric oxide.

290 s low micromolar, or iNOS-derived, levels of nitric oxide.

291 thought to be targets of endothelium-derived nitric oxide.

292 oline receptors and are mediated through the nitric oxide/cGMP/protein kinase G pathway.

293 The activity is critical in initiating a nitric oxide/S-nitrosylation-dependent signal transducti

294 acorporeal membrane oxygenation, and inhaled nitric oxide; Pao2:Fio2 ratio measured daily from day 1

295 stress stimuli and haemoglobin scavenging of nitric oxide; these two regulatory factors have not been

296 Tyr-99 revealed that this nitration reduces nitric-oxide production and increases eNOS decoupling co

297 n species caused by dysregulated endothelial nitric-oxide synthase (eNOS) activity is linked to vascu

298 gulate expression of the inflammatory marker nitric-oxide synthase 2.

299 levels of proinflammatory markers: inducible nitric-oxide synthase and tumor necrosis factor-alpha, w

300 we develop a step towards protocell-mediated nitric-oxide-induced vasodilation by constructing a new